CollPlant Biotechnologies expanded its European distribution network for Vergenix STR through the signing of a new agreement in Poland. Vergenix STR is based on the company’s rhCollagen technology and is intended for the treatment of tendinopathy by promoting healing and repair of tendon injuries in a variety of tendons.
Vergenix STR is a soft tissue repair matrix specifically designed for combination with platelet-rich plasma (PRP). Upon mixing, it forms a scaffold with delayed degradation and strong retention at the injury site, supporting a localized and sustained therapeutic effect. The product is intended to promote tendon healing across multiple indications, including lateral epicondylitis, rotator cuff injuries, patellar tendinopathy, Achilles tendon injuries, and hand tendon repairs.
Yehiel Tal, Chief Executive Officer of CollPlant, commented: “As we expand our distribution network across Europe and the Asia-Pacific region, we are excited about the significant market potential for Vergenix™ STR. The product provides a differentiated treatment for tendon injuries by forming a gel matrix that enables localized, sustained release of growth factors at the injury site, thereby supporting optimal healing. We expect to deliver the first shipment to our distributor by the end of this year and look forward to further broadening our global distribution network for Vergenix™ STR in additional territories.”
CollPlant Biotechnologies expanded its European distribution network for Vergenix STR through the signing of a new agreement in Poland. Vergenix STR is based on the company's rhCollagen technology and is intended for the treatment of tendinopathy by promoting healing and repair of tendon injuries in a variety of tendons.
Vergenix STR is a soft...
CollPlant Biotechnologies expanded its European distribution network for Vergenix STR through the signing of a new agreement in Poland. Vergenix STR is based on the company’s rhCollagen technology and is intended for the treatment of tendinopathy by promoting healing and repair of tendon injuries in a variety of tendons.
Vergenix STR is a soft tissue repair matrix specifically designed for combination with platelet-rich plasma (PRP). Upon mixing, it forms a scaffold with delayed degradation and strong retention at the injury site, supporting a localized and sustained therapeutic effect. The product is intended to promote tendon healing across multiple indications, including lateral epicondylitis, rotator cuff injuries, patellar tendinopathy, Achilles tendon injuries, and hand tendon repairs.
Yehiel Tal, Chief Executive Officer of CollPlant, commented: “As we expand our distribution network across Europe and the Asia-Pacific region, we are excited about the significant market potential for Vergenix™ STR. The product provides a differentiated treatment for tendon injuries by forming a gel matrix that enables localized, sustained release of growth factors at the injury site, thereby supporting optimal healing. We expect to deliver the first shipment to our distributor by the end of this year and look forward to further broadening our global distribution network for Vergenix™ STR in additional territories.”
Copy to clipboard 
